Combating Fungal Infections: Problems and Remedy
ISBN-13:
9783642121722
ISBN-10:
3642121721
Edition:
2010
Author:
Mohammed Shahid, Iqbal Ahmad, Farrukh Aqil, Mohammad Owais
Publication date:
2010
Publisher:
Springer
Format:
Hardcover
559 pages
Category:
Biology
,
Immunology
,
Basic Medical Sciences
,
Pharmacology
,
Biological Sciences
FREE US shipping
Book details
ISBN-13:
9783642121722
ISBN-10:
3642121721
Edition:
2010
Author:
Mohammed Shahid, Iqbal Ahmad, Farrukh Aqil, Mohammad Owais
Publication date:
2010
Publisher:
Springer
Format:
Hardcover
559 pages
Category:
Biology
,
Immunology
,
Basic Medical Sciences
,
Pharmacology
,
Biological Sciences
Summary
Combating Fungal Infections: Problems and Remedy (ISBN-13: 9783642121722 and ISBN-10: 3642121721), written by authors
Mohammed Shahid, Iqbal Ahmad, Farrukh Aqil, Mohammad Owais, was published by Springer in 2010.
With an overall rating of 3.8 stars, it's a notable title among other
Biology
(Immunology, Basic Medical Sciences, Pharmacology, Biological Sciences) books. You can easily purchase or rent Combating Fungal Infections: Problems and Remedy (Hardcover) from BooksRun,
along with many other new and used
Biology
books
and textbooks.
And, if you're looking to sell your copy, our current buyback offer is $0.3.
Description
Fungi are eukaryotic microorganisms that are closely related to humans at cellular level. Human fungal pathogens belong to various classes of fungi, mainly zygo- cetes, ascomycetes, basidiomycetes, and deuteromycetes. In recent years, fungal infections have dramatically increased as a result of improved diagnosis, high frequency of catheterization, instrumentation, etc. However, the main cause remains the increasing number of immunosuppressed patients, mostly because of HIV infection and indiscriminate usage of antineoplastic and immunosuppressive agents, broad-spectrum antibiotics and prosthetic devices, and grafts in clinical settings. Presently available means of combating fungal infections are still weak and clumsy compared to control of bacterial infection. The present scenario of antifungal therapy is still based on two classes of antifungal drugs (polyenes and azoles). These drugs are effective in many cases, but display toxicity and limited spectrum of ef?cacy. The recent trend towards emergence of drug-resistant isolates in the clinic is an additional problem. In recent years, a few new antifungal drugs have entered the clinics, but they are expected to undergo same fate as the older antifungal drugs. The application of fungal genomics offers an unparalleled opportunity to develop novel antifungal drugs. However, it is too early to expect any novel drugs, as the antifungal drug discovery program is in the stage of infancy. Interestingly, several novel antifungal drug targets have been identi?ed and validated.
We would LOVE it if you could help us and other readers by reviewing the book
Book review
Congratulations! We have received your book review.
{user}
{createdAt}
by {truncated_author}